Immuron CEO, Steven Lydeamore Investor Webinar Presentation
February 08 2024 - 6:00AM
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and
globally integrated biopharmaceutical company is pleased to advise
our Chief Executive Officer, Steven Lydeamore will be presenting at
the Monsoon Communications Investor function on Thursday, 8th
February in Sydney, Australia.
A copy of the presentation slide deck is
available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
Authorized for release by the Board of Immuron
Limited.
COMPANY
CONTACT:Steven Lydeamore Chief
Executive Officer Ph: +61 (0)3 9824
5254info@immuron.com
About
ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN),
is an Australian biopharmaceutical company focused on developing
and commercialising orally delivered targeted polyclonal antibodies
for the treatment of infectious diseases.
For more information visit:
http://www.immuron.com
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Jul 2023 to Jul 2024